In February 2026, Lilly also introduced multi-dose KwikPen devices through LillyDirect at $299 to $449 per month
Metabolic indicators that may be associated with reduced GLP-1 activity include: Persistent elevated blood glucose levels , particularly postprandial (after-meal) hyperglycaemia Difficulty achieving or maintaining a healthy weight despite dietary efforts Increased appetite and reduced satiety after meals, leading to frequent snacking Diagnosis of type 2 diabetes or non-diabetic hyperglycaemia (NDH, sometimes called prediabetes), conditions where GLP-1 response is often blunted Features of metabolic syndrome , including central obesity, hypertension, and dyslipidaemia Individuals may also notice practical symptoms such as feeling hungry shortly after eating substantial meals, experiencing energy crashes following carbohydrate-rich foods, or finding portion control particularly challenging
Ensuring adequate sleep is important too, as rest is essential for recovery and detoxification
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
Traditional supplements break down during digestion